Yasmeen Long, M.A.

Yasmeen Long, M.A., is a nationally recognized expert in biomedical research, health outcomes, domestic and global policy, patient advocacy, and stakeholder engagement. Long has earned media featured in Forbes, Modern Healthcare, Bloomberg Law, Endpoints News, National Journal, Science News, The Scientist Magazine, and Regulatory Focus. Long is a former director at FasterCures of the Milken Institute. She created, developed, and led the first health equity and diversity in clinical trials program at the Institute during the height of the COVID-19 pandemic. Long’s impactful work led to federal policy development and implementation. 

Prior to joining the Milken Institute, Long served as the co-director of the Health Policy Fellowships and Leadership Programs at the National Academy of Medicine. She also served as a program officer at the Patient-Centered Outcomes Research Institute (PCORI) where she executed strategic objectives to advance patient and stakeholder engagement in patient-centered outcomes research and comparative effectiveness research. Prior to PCORI, she directed global health policy and tobacco control programs in the U.S., Asia, and the Middle East at the Johns Hopkins Bloomberg School of Public Health in collaboration with the Bloomberg Philanthropies, and the World Health Organization. 

Earlier in her career, she managed research programs at the Johns Hopkins School of Medicine, and the Massachusetts General Hospital and Harvard Medical School in the following areas: clinical research, chronic and infectious diseases, and disparities in patient care. Long earned an M.A. in sociology and women's health from Suffolk University and a B.Sc. in health sciences and management from Howard University.